The real-time monitoring feature of the system allows medical personnel to comprehensively understand the patients respiratory condition and promptly detect any abnormal situations
Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials
DITCH SURROGATE CARDIOVASCULAR PARAMETERS IN GUIDING ANAESTHESIA
Impact of GLP-1 Drug Adoption on Consumer Food Demand GLP-1 weight loss drugs are likely to impact long-term category growth rates for food consumption
Hims just held its Q2 earnings call, and well center the bulk of the conversation and controversy around them given the public availability of information along with the amount of discussion GLP-1s generated during the Q&A
Energy, workout performance, recovery, cravings, and soreness can all give useful feedback
